For the quarter ending 2026-03-31, IART made $391,918K in revenue. -$4,617K in net income. Net profit margin of -1.18%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue, net | 391,918 | 434,925 | 402,062 | 415,605 |
| Goodwill impairment charge | - | 0 | 0 | 511,365 |
| Cost of goods sold | 174,936 | 214,060 | 195,071 | 206,273 |
| Research and development | 23,501 | 24,790 | 22,456 | 26,997 |
| Selling, general and administrative | 178,235 | 169,267 | 169,046 | 179,890 |
| Intangible asset amortization | 3,776 | 3,768 | 3,728 | 3,754 |
| Total costs and expenses | 380,448 | 411,885 | 390,301 | 928,279 |
| Operating income (gain) | 11,470 | 23,040 | 11,761 | -512,674 |
| Interest income | 4,106 | 4,362 | 4,982 | 4,710 |
| Interest expense | 22,465 | 23,673 | 22,725 | 21,042 |
| Other income (expense), net | 4,480 | 581 | -842 | -1,946 |
| Gain before income taxes | -2,409 | 4,310 | -6,824 | -530,952 |
| Provision for income taxes | 2,208 | 6,014 | -1,420 | -46,879 |
| Net loss | -4,617 | -1,704 | -5,404 | -484,073 |
| Basic EPS | -0.06 | -0.022 | -0.07 | -6.31 |
| Diluted EPS | -0.06 | -0.022 | -0.07 | -6.31 |
| Basic Average Shares | 76,951,000 | 76,777,000 | 76,753,000 | 76,695,000 |
| Diluted Average Shares | 76,951,000 | 76,777,000 | 76,753,000 | 76,695,000 |
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)